VERACYTE, INC.·4

Dec 4, 4:59 PM ET

Febbo Phillip G. 4

4 · VERACYTE, INC. · Filed Dec 4, 2024

Insider Transaction Report

Form 4
Period: 2024-12-02
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
  • Tax Payment

    Common Stock

    2024-12-02$44.12/sh6,738$297,28186,348 total
Footnotes (1)
  • [F1]The reporting person is reporting the withholding of 6,738 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 13,295 Restricted Stock Units granted on October 2, 2023 and does not represent a sale by the reporting person.

Documents

1 file
  • 4
    wk-form4_1733349551.xmlPrimary

    FORM 4